A TLR4/NF‐κB/IRF4 signaling pathway is indispensable for M. elsdenii‐mediated DC activation and thereby leads to the augment of colonic Th1 and Th17 inflammation, resulting in an exacerbation of colitis‐associated tumorigenesis. This evidence concerns the gene IRF4 and colitis.